Patents, Trademarks, Trade Secrets, and Copyrights Oh My!


SCOTUS Justices skeptical Amgen's patents are enabled

"Amgen says it should be able to lay claim to a whole area of potentially unexplored research in a single patent, while Sanofi, Regenron, and the government argue that such patents do not contain enough information to be protected."
Bloomberg Law
2023-03-28 06:45:43